These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31067516)

  • 21. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.
    Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
    Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Stem Cells and Their Therapeutic Usage.
    Osum M; Kalkan R
    Adv Exp Med Biol; 2023; 1436():69-85. PubMed ID: 36689167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Patel S; Shah K; Mirza S; Daga A; Rawal R
    Curr Stem Cell Res Ther; 2015; 10(2):140-52. PubMed ID: 25330402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
    Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
    Shibue T; Weinberg RA
    Nat Rev Clin Oncol; 2017 Oct; 14(10):611-629. PubMed ID: 28397828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y; Kim D; Sohn H; Lim W
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells.
    Lan L; Luo Y; Cui D; Shi BY; Deng W; Huo LL; Chen HL; Zhang GY; Deng LL
    Int J Oncol; 2013 Jul; 43(1):113-20. PubMed ID: 23604232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance.
    Chang JC
    Medicine (Baltimore); 2016 Sep; 95(1 Suppl 1):S20-S25. PubMed ID: 27611935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spotlight on regulatory networks connecting EMT and cancer stem cells.
    Zavadil J
    Cell Cycle; 2010 Aug; 9(15):2927. PubMed ID: 20703080
    [No Abstract]   [Full Text] [Related]  

  • 39. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic and metabolic regulation of breast cancer stem cells.
    Liu HX; Li XL; Dong CF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.